Zhaowen Zhu

发表

BRAF copy number gains in thyroid tumors detected by fluorescence In Situ hybridization

Y. Nikiforov, R. Ciampi, Zhaowen Zhu, 2005, Endocrine pathology.

Molecular classification of papillary thyroid carcinoma: distinct BRAF, RAS, and RET/PTC mutation-specific gene expression profiles discovered by DNA microarray analysis

David E. Misek, R. Kuick, S. Hanash, 2005, Oncogene.

High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma.

Yuri E Nikiforov, Marina N Nikiforova, M. Nikiforova, 2003, Cancer research.

Prevalence of RET/PTC rearrangements in thyroid papillary carcinomas: effects of the detection methods and genetic heterogeneity.

M. Nikiforova, Y. Nikiforov, R. Ciampi, 2006, The Journal of clinical endocrinology and metabolism.

Oncogenic AKAP9-BRAF fusion is a novel mechanism of MAPK pathway activation in thyroid cancer.

M. Nikiforova, Y. Nikiforov, J. Fagin, 2005, The Journal of clinical investigation.

Molecular profile and clinical-pathologic features of the follicular variant of papillary thyroid carcinoma. An unusually high prevalence of ras mutations.

A. Fischer, M. Nikiforova, Y. Nikiforov, 2003, American journal of clinical pathology.

Delineation, Functional Validation, and Bioinformatic Evaluation of Gene Expression in Thyroid Follicular Carcinomas with the PAX8-PPARG Translocation

David E. Misek, A. Chinnaiyan, R. Kuick, 2006, Clinical Cancer Research.

An Audit to Evaluate Vancomycin Therapeutic Drug Monitoring in a Neonatal Intensive Care Unit

Zhaowen Zhu, M. Luig, J. Alffenaar, 2022, Therapeutic drug monitoring.

Multicenter phase II trial of Camrelizumab combined with Apatinib and Eribulin in heavily pretreated patients with advanced triple-negative breast cancer

H. Yao, Ying Lin, Zhaowen Zhu, 2022, Nature Communications.

Molecular testing for mutations in improving the fine-needle aspiration diagnosis of thyroid nodules.

M. Nikiforova, Y. Nikiforov, D. Steward, 2009, The Journal of clinical endocrinology and metabolism.

Dose-dependent generation of RET/PTC in human thyroid cells after in vitro exposure to gamma-radiation: a model of carcinogenic chromosomal rearrangement induced by ionizing radiation.

Y. Nikiforov, J. Stringer, R. Ciampi, 2005, The Journal of clinical endocrinology and metabolism.

BRAF mutations in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinomas.

M. Nikiforova, Y. Nikiforov, M. Santoro, 2003, The Journal of clinical endocrinology and metabolism.

Correlation Between Genetic Alterations and Microscopic Features, Clinical Manifestations, and Prognostic Characteristics of Thyroid Papillary Carcinomas

T. Giordano, Y. Nikiforov, D. Steward, 2006, The American journal of surgical pathology.

Advances in Brief High Prevalence of BRAF Mutations in Thyroid Cancer : Genetic Evidence for Constitutive Activation of the RET / PTC-RAS-BRAF Signaling Pathway in Papillary Thyroid Carcinoma 1

M. Nikiforova, Y. Nikiforov, J. Fagin, 2003 .

The ceRNA Network Has Potential Prognostic Value in Clear Cell Renal Cell Carcinoma: A Study Based on TCGA Database

Zhaowen Zhu, Jianxiong Fang, Jiumin Liu, 2020, BioMed research international.

Molecular testing for mutations in improving the fine-needle aspiration diagnosis of thyroid nodules.

M. Nikiforova, Y. Nikiforov, D. Steward, 2009, The Journal of clinical endocrinology and metabolism.